KNNKF yields 16.05% · PFE yields 6.13%● Live data
📍 KNNKF pulled ahead of the other in Year 1
Combined, KNNKF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KNNKF + PFE for your $10,000?
Kanematsu Sustech Corporation engages in the geo-tech, wood and housing materials, and CCTV systems businesses. The company offers ground stabilization through various construction methods; resurfacing of grounds; cement and steel foundation file repairs; ecological pile repairs; and ground inspections and sinkage repairs. It engages in the processing and sales of wet and dry wet method preservative treatment; sale of chemical; and drying timber. In addition, it sells security camera; and engages in installation works. The company was formerly known as Kanematsu-NNK Corporation and changed its name to Kanematsu Sustech Corporation in October 2016. Kanematsu Sustech Corporation was incorporated in 1934 and is headquartered in Tokyo, Japan. Kanematsu Sustech Corporation is a subsidiary of Kanematsu Corporation.
Full KNNKF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.